GENERAL
Morepen Completes 1st Phase of API, CDMO Expansion Ahead Of Schedule
Morepen Laboratories has completed the first phase of its manufacturing capacity expansion programme ahead of schedule, increasing its installed reactor capacity for active pharmaceutical ingredients (API) and contract development and manufacturing organisation (CDMO) operations from 535 KL to 614 KL. The capacity addition is expected to strengthen Morepen Laboratories’ manufacturing readiness as the company scales […]
CW Bureau
·
Sep 7, 2026
STARTUP/TECHNOLOGY
RPG Life Sciences Arm To Acquire Raghava Life Sciences API For ₹135 Cr
RPG Life Sciences Ltd’s wholly owned subsidiary RPG Active Pharma Ltd (RPGAP) has entered into a Business Transfer Agreement to acquire the Active Pharmaceutical Ingredients (API) and intermediates business of Raghava Life Sciences Pvt Ltd for ₹135 crore. The business will be acquired on a going-concern basis through a slump sale. The transaction is part […]
CW Bureau
·
Sep 3, 2026
GENERAL
Gland Pharma Partners With Neuland Labs To Expand Sterile API Capacity
Gland Pharma and Neuland Laboratories have entered into a long-term strategic contract development and manufacturing organisation (CDMO) partnership to strengthen their presence in the fast-growing sterile active pharmaceutical ingredient (API) segment. As part of the collaboration, Gland Pharma will establish a dedicated sterile manufacturing suite for APIs used in microparticle depot products at its JNPC […]
CW Bureau
·
Aug 5, 2026
